Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Operating Margin (2020 - 2025)

Historic Operating Margin for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to 2.78%.

  • GeneDx Holdings' Operating Margin rose 73400.0% to 2.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.48%, marking a year-over-year increase of 240600.0%. This contributed to the annual value of 7.6% for FY2024, which is 815500.0% up from last year.
  • Per GeneDx Holdings' latest filing, its Operating Margin stood at 2.78% for Q3 2025, which was up 73400.0% from 8.73% recorded in Q2 2025.
  • GeneDx Holdings' 5-year Operating Margin high stood at 9.21% for Q4 2024, and its period low was 529.56% during Q4 2022.
  • Moreover, its 5-year median value for Operating Margin was 96.67% (2021), whereas its average is 129.99%.
  • Per our database at Business Quant, GeneDx Holdings' Operating Margin plummeted by -3530200bps in 2022 and then soared by 4848900bps in 2023.
  • Over the past 5 years, GeneDx Holdings' Operating Margin (Quarter) stood at 200.31% in 2021, then plummeted by -164bps to 529.56% in 2022, then surged by 92bps to 44.66% in 2023, then surged by 121bps to 9.21% in 2024, then crashed by -130bps to 2.78% in 2025.
  • Its Operating Margin stands at 2.78% for Q3 2025, versus 8.73% for Q2 2025 and 5.22% for Q1 2025.